News section
home news forum careers events suppliers solutions markets resources directories advertise contacts search site plan
 
.
Bayer CropScience granted new license to Senesco Technologies' gene technology for cotton

.

New Brunswick, New Jersey
July 24, 2007

Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX: SNT) announced today that Bayer CropScience was granted the exclusive rights to Senesco's proprietary gene technology for use in cotton. The agreement anticipates that the licensed technology will enable Bayer CropScience to significantly enhance cotton fiber and seed yields in its flagship FiberMax® brand on a global basis. In return, Senesco will receive success-bound development milestone and royalty payments upon commercialization. Specific financial terms of the transaction were not disclosed.

"In November 2006, Senesco and Bayer CropScience entered into an exclusive license agreement for use of Senesco's gene technology in canola. That agreement established a strong working relationship between our companies. We are very pleased to build upon that relationship with this new license agreement for cotton," said Bruce Galton, President of Senesco.

Dr. Michiel van Lookeren Campagne, Head of Research at BioScience, a business operations unit of Bayer CropScience, welcomes the new business relationship with Senesco: "After the successful conclusion of our agreement with Senesco on canola last year, we are pleased that we could now extend this relationship to Cotton as well. Bayer CropScience has grown to be a leading company in the cotton seed market with FiberMax®, our high quality, high yield cotton varieties. We anticipate that the innovative Senesco technology will contribute to further strengthen our leadership position in the global cotton markets."

Senesco Technologies, Inc. is a U.S. biotechnology company.
Senesco has initiated preclinical research to trigger or delay cell death in mammals (apoptosis) to determine if the technology is applicable in human medicine. Accelerating apoptosis may have applications to development of cancer treatments. Delaying apoptosis may have applications to certain diseases such as glaucoma, ischemia and arthritis, among others. Senesco takes its name from the scientific term for the aging of plant cells: senescence. The Company has developed technology that regulates the onset of cell death.
Delaying cell breakdown in plants extends freshness after harvesting, while increasing crop yields, plant size and resistance to environmental stress for flowers, fruits and vegetables. In addition to its human health research programs, the Company believes that its technology can be used to develop superior strains of crops without any modification other than delaying natural plant senescence. Senesco has partnered with leading-edge companies engaged in agricultural biotechnology and earns research and development fees for applying its gene-regulating platform technology to enhance its partners' products.
Senesco is headquartered in New Brunswick, New Jersey.

Bayer CropScience AG, a subsidiary of Bayer AG, is one of the world's leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and plant biotechnology. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of about 17,900 and is represented in more than 120 countries.

More news from Bayer CropScience

 

 

 

 

The news item on this page is copyright by the organization where it originated - Fair use notice

Other news from this source


Copyright © SeedQuest - All rights reserved